1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Chlamydia Infections Global Clinical Trials Review, H2, 2014

Chlamydia Infections Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Chlamydia Infections Global Clinical Trials Review, H2, 2014" provides data on the Chlamydia Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chlamydia Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chlamydia Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Chlamydia Infections Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Chlamydia Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Chlamydia Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Chlamydia Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Chlamydia Infections 23
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Chlamydia Infections Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Kyorin Holdings, Inc. 31
Clinical Trial Overview of Kyorin Holdings, Inc. 31
Endo International plc 32
Clinical Trial Overview of Endo International plc 32
Cempra Pharmaceuticals, Inc. 33
Clinical Trial Overview of Cempra Pharmaceuticals, Inc. 33
ActivBiotics Pharma, LLC 34
Clinical Trial Overview of ActivBiotics Pharma, LLC 34
Actavis plc 35
Clinical Trial Overview of Actavis plc 35
Clinical Trial Overview of Top Institutes / Government 36
University of California, San Francisco 36
Clinical Trial Overview of University of California, San Francisco 36
Johns Hopkins University 37
Clinical Trial Overview of Johns Hopkins University 37
Centers for Disease Control and Prevention 38
Clinical Trial Overview of Centers for Disease Control and Prevention 38
National Heart, Lung, and Blood Institute 39
Clinical Trial Overview of National Heart, Lung, and Blood Institute 39
University of Pittsburgh 40
Clinical Trial Overview of University of Pittsburgh 40
The University of Melbourne 41
Clinical Trial Overview of The University of Melbourne 41
Washington University School of Medicine 42
Clinical Trial Overview of Washington University School of Medicine 42
London School of Hygiene and Tropical Medicine 43
Clinical Trial Overview of London School of Hygiene and Tropical Medicine 43
Population Council 44
Clinical Trial Overview of Population Council 44
Barts and The London NHS Trust 45
Clinical Trial Overview of Barts and The London NHS Trust 45
Five Key Clinical Profiles 46
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 67

List of Tables

Chlamydia Infections Therapeutics, Global, Clinical Trials by Region, 2014* 7
Chlamydia Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chlamydia Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Chlamydia Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Chlamydia Infections Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Chlamydia Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Chlamydia Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Chlamydia Infections Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Chlamydia Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Chlamydia Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Chlamydia Infections Therapeutics, Global, Suspended Clinical Trials, 2014* 23
Chlamydia Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Chlamydia Infections Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Chlamydia Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Chlamydia Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Chlamydia Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Chlamydia Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Chlamydia Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyorin Holdings, Inc., 2014* 31
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo International plc, 2014* 32
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra Pharmaceuticals, Inc., 2014* 33
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by ActivBiotics Pharma, LLC, 2014* 34
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 35
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 36
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 37
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014* 38
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 39
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 40
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Melbourne, 2014* 41
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 42
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene and Tropical Medicine, 2014* 43
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Population Council, 2014* 44
Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Barts and The London NHS Trust, 2014* 45

List of Figures

Chlamydia Infections Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Chlamydia Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chlamydia Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Chlamydia Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Chlamydia Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Chlamydia Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Chlamydia Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Chlamydia Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Chlamydia Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Chlamydia Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Chlamydia Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Chlamydia Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Chlamydia Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Chlamydia Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 66

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.